HLA-DRB1 confers increased risk of pediatric-onset MS in children with acquired demyelination

Neurology

Volumn 76, Issue 9, 2011, Pages 781-786

  Disanto, G ^a,b   Magalhaes, S ^c   Handel, A E ^a,b   Morrison, K M ^a,b   Sadovnick, A D ^d   Ebers, G C ^a,b   Banwell, B ^e   Bar Or, A ^c  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c MCGILL UNIVERSITY   (Canada)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DR ANTIGEN;

ADOLESCENT; ARTICLE; CAUCASIAN; CHILD; CONTROLLED STUDY; DEMYELINATION; FEMALE; FOLLOW UP; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK ASSESSMENT; SCHOOL CHILD;

EID: 79952379414     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e31820ee1cd     Document Type: Article

References (15)

1. Banwell B, Ghezzi A, Bar-Or A, Mikaeloff Y, Tardieu M. Multiple sclerosis in children: clinical diagnosis, therapeutic strategies, and future directions. Lancet Neurol 2007;6: 887-902. (Pubitemid 47405001)
2. Mikaeloff Y, Suissa S, Vallee L, et al. First episode of acute CNS inflammatory demyelination in childhood: prognostic factors for multiple sclerosis and disability. J Pediatr 2004;144:246-252. (Pubitemid 38869403)
3. Lincoln MR, Montpetit A, Cader MZ, et al. A predominant role for the HLA class II region in the association of the MHC region with multiple sclerosis. Nat Genet 2005; 37:1108-1112. (Pubitemid 41486664)
4. Fogdell A, Hillert J, Sachs C, Olerup O. The multiple sclerosis-and narcolepsy-associated HLA class II haplotype includes the DRB5*0101 allele. Tissue Antigens 1995;46: 333-336.
5. Boiko AN, Gusev EI, Sudomoina MA, et al. Association and linkage of juvenile MS with HLA-DR2(15) in Russians. Neurology 2002;58:658-660. (Pubitemid 34164957)
6. Idrissova ZR, Boldyreva MN, Dekonenko EP, et al. Acute disseminated encephalomyelitis in children: clinical features and HLA-DR linkage. Eur J Neurol 2003;10:537-546. (Pubitemid 38021469)
7. Krupp LB, Banwell B, Tenembaum S. Consensus definitions proposed for pediatric multiple sclerosis and related disorders. Neurology 2007;68(suppl 2):S7-S12. (Pubitemid 46626001)
8. Banwell B, Kennedy J, Sadovnick D, et al. Incidence of acquired demyelination of the CNS in Canadian children. Neurology 2009;72:232-239.
9. Poser CM. The Diagnosis of Multiple Sclerosis. New York: Thieme-Stratton; 1984.
10. Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria." Ann Neurol 2005;58:840-846. (Pubitemid 41746873)
11. Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG. Revised diagnostic criteria for neuromyelitis optica. Neurology 2006;66:1485-1489. (Pubitemid 43958540)
12. Sadovnick AD, Risch NJ, Ebers GC. Canadian collaborative project on genetic susceptibility to MS, phase 2: rationale and method: Canadian Collaborative Study Group. Can J Neurol Sci 1998;25:216-221. (Pubitemid 28368797)
13. Olerup O, Zetterquist H. HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 1992;39:225-235.
14. Banwell B, Krupp L, Kennedy J, et al. Clinical features and viral serologies in pediatric multiple sclerosis: results of multinational study. Lancet Neurol 2007;6: 773-781. (Pubitemid 47238663)
15. Nilsson P, Larsson EM, Maly-Sundgren P, Perfekt R, Sandberg-Wollheim M. Predicting the outcome of optic neuritis: evaluation of risk factors after 30 years of followup. J Neurol 2005;252:396-402. (Pubitemid 40576901)